» Articles » PMID: 1967540

A De Novo and Heterozygous Gene Deletion Causing a Variant of Von Willebrand Disease

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1990 Feb 1
PMID 1967540
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

An abnormal von Willebrand factor (vWF) gene restriction pattern has been found in a patient with von Willebrand disease. Because this gene alteration is not present in his parents or in 50 normal and 25 affected subjects, and the restriction fragment length polymorphism haplotypes are inherited normally in the patient's family, we suggest that a de novo mutation is present. Bands with reduced intensity and additional fragments, observed in several restriction digests, hybridize with noncontiguous copy DNA (cDNA) portions, thus indicating the presence of a heterozygous gene deletion. The deletion removes a genomic region containing at least codons 1147 through 1854 and corresponding to the D3-A3 homologous protein domains. The extent of the vWF pseudogene on chromosome 22 is roughly similar to that of the deleted area. However, the pseudogenic nature of the deletion is excluded by the mapping of bands with reduced intensity in the patient to the true vWF gene. The vWF antigen levels are one fourth of normal and ristocetin cofactor activity is severely impaired. The reduction of high molecular weight multimers in plasma and platelets and the altered triplet morphology are compatible with the presence of a dominant variant of type II von Willebrand disease.

Citing Articles

The future of siRNA-mediated approaches to treat von Willebrand disease.

Linthorst N, van Vlijmen B, van Vlijmen B, Eikenboom J, Eikenboom J Expert Rev Hematol. 2025; 18(2):109-122.

PMID: 39865861 PMC: 11854048. DOI: 10.1080/17474086.2025.2459259.


Origin and timing of de novo variants implicated in type 2 von Willebrand disease.

Chen M, Shen M, Chang S, Ma G, Huang Y, Lin C J Cell Mol Med. 2022; 26(21):5403-5413.

PMID: 36226571 PMC: 9639050. DOI: 10.1111/jcmm.17563.


The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.

Hampshire D, Goodeve A Haematologica. 2011; 96(6):798-800.

PMID: 21632843 PMC: 3105639. DOI: 10.3324/haematol.2011.046623.


Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region.

Bernardi F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M Hum Genet. 1993; 92(5):446-50.

PMID: 8244334 DOI: 10.1007/BF00216448.


Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Schneppenheim R, Krey S, Bergmann F, Bock D, Budde U, Lange M Hum Genet. 1994; 94(6):640-52.

PMID: 7989040 DOI: 10.1007/BF00206958.